| Literature DB >> 30406098 |
Anna Denchai1, Daniele Tartarini2, Elisa Mele1.
Abstract
Surface properties of biomaterials, such as chemistry and morphology, have a major role in modulating cellular behavior and therefore impact on the development of high-performance devices for biomedical applications, such as scaffolds for tissue engineering and systems for drug delivery. Opportunely-designed micro- and nanostructures provides a unique way of controlling cell-biomaterial interaction. This mini-review discusses the current research on the use of electrospinning (extrusion of polymer nanofibers upon the application of an electric field) as effective technique to fabricate patterns of micro- and nano-scale resolution, and the corresponding biological studies. The focus is on the effect of morphological cues, including fiber alignment, porosity and surface roughness of electrospun mats, to direct cell migration and to influence cell adhesion, differentiation and proliferation. Experimental studies are combined with computational models that predict and correlate the surface composition of a biomaterial with the response of cells in contact with it. The use of predictive models can facilitate the rational design of new bio-interfaces.Entities:
Keywords: bio-interfaces; electrospinning; mathematical modeling; micro-patterning; surface topography
Year: 2018 PMID: 30406098 PMCID: PMC6207584 DOI: 10.3389/fbioe.2018.00155
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Summary of the recent literature on the use of electrospun fibers to control morphology, alignment and differentiation of diverse cell lines.
| Human MSCs | Poly (ε-caprolactone) | Randomly distributed fibers; Diameter: ~ 630 nm; Surface roughness: ~ 2 μm. | Recruitment of MSCs | Zhang et al., |
| Human MSCs | Poly (ε-caprolactone); Poly (ε-caprolactone)-gelatine | Randomly distributed and aligned fibers; Diameter: 600–780 nm; Porosity: 78–86%. | Cardiomyogenesis; Cytoskeletal arrangement; Changes in the cellular and nuclear morphology. | Ghosh et al., |
| Human MSCs | Poly (L-lactic acid) | Randomly distributed and aligned fibers coated with poly (3,4-ethylenedioxythiophene; Diameter: ~ 950 nm. | Synergic effect of fiber alignment and electrical stimulation; Promotion of cellular activity and proliferation. | Jin et al., |
| Human adipose-derived MSCs | Poly (L-lactide ε-caprolactone) and fibrinogen | Random and aligned fibers; Diameter: 200–500 nm; Patterning of electrospun mats using honeycomb shaped collector produced by photolithography; Honeycomb: 160 μm internal diameter, walls of 20 μm width and 60 μm height. | Homotypic interaction of MSCs on honeycomb scaffolds; Osteogenic differentiation of MSCs on honeycomb scaffolds. | Nedjari et al., |
| Human adipose-derived MSCs | SU-8 photoresist | Randomly oriented fibers; Diameter: 550 nm; Patterning of electrospun mats by photolithography; Pattern dimensions: 20 μm ridges, 20 μm grooves, 5 μm pattern height. | Orientation and alignment of cells resembling the | Sankar et al., |
| Human bone marrow MSCs | Poly (ε-caprolactone) | Random-aligned-random structure; Diameter: 240–450 nm. | Regional induction of MSCs toward tenogenesis and osteogenesis; Collagen deposition. | Lin et al., |
| Human dental pulp MSCs | Polystyrene | Randomly distributed fibers; Diameter: 300–500 nm; Surface roughness: 0.8 μm. | Increased the expression of bone morphogenetic proteins and Wnt ligands; Odontoblast differentiation of MSCs; Dentin regeneration. | Rahman et al., |
| Mouse MSCs (C3H10T1/2) | Poly (L-lactic acid) | Random and aligned fibers; Diameter: 740–1070 nm. | Up-regulation of tendon-specific markers for MSCs on aligned fibers; Tendon-like tissue regeneration | Yin et al., |
| Mouse MSCs (C3H10T1/2) | Polylactic acid and polycaprolactone | Random and aligned coaxial fibers; Diameter: ~ 2 μm; Porosity: 82–84%. | Expression of tendon-related markers; Tenogenic differentiation of mouse MSCs. | Baudequin et al., |
| Rat bone marrow MSCs | Poly (ε-caprolactone) and poly (ethylene glycol); Chitosan | Random and aligned fibers; Diameter: 200–600 nm; 3D multi-layered scaffolds: layers of fibers within a porous chitosan matrix. | Ligamentogenesis and partially decreased osteogenesis for MSCs for aligned nanofibers embedded scaffolds | Jiang et al., |
| Rat bone marrow MSCs | Poly (ε-caprolactone) | Random and aligned fibers; Diameter: 820–1000 nm; Application of mechanical tension-stress after cell seeding. | Osteogenic differentiation of MSCs onto aligned fibers; Expression of osteogenic genes on aligned fibers; enhanced expression of osteogenic genes after mechanical stimulation. | Liu et al., |
| Rat adipose-derived MSCs | Poly (ε-caprolactone) | Random and aligned fibers; Diameter: 1 μm; Patterning of electrospun mats using copper mesh with grid length of 830 μm as collector. | Upregulated levels of anti-inflammatory and pro-angiogenic cytokines | Su et al., |
| HUVECs | Poly (D,L-lactide) and polycaprolactone | Random and aligned fibers; Diameter: 500–700 nm; Patterning of electrospun mats using a wire spring with interval distances of 300, 800, and 1500 μm as collector. | Modification of cytoskeleton morphology; Cell alignment and polarization on aligned fibers; Expression of angiogenesis-related genes. | Xu et al., |
| HUVECs | Polycaprolactone and polyethyleneoxide | Nanostructured, random fibers. Diameter: 4–20 μm. | Enhanced cells' proliferation; Stimulation of adhesion complex formation on nanotextured fibers. | Taskin et al., |
| HUVECs | Poly (L-lactide) | Random and aligned fibers; Patterning of electrospun mats by femtosecond laser ablation; Pattern dimensions: grooves distance of 20.9 and 81.3 μm; grooves width of 9.4 and 7.6 μm; grooves depth of 12.5 and 13.9 μm. | Changes in morphology and orientation of cells on micropatterned scaffolds; Reduction of monocytes adhesion on the micropatterned mats; Anti-inflammatory response. | Shin et al., |
| HUVECs | Poly (L-lactic acid) | Random fibers; Diameter: 540 nm; Patterning of electrospun mats by hot embossing; Pattern dimensions: 50, 100, and 200 μm wide grooves. | Cells alignment along the direction of the grooves; Expression of endothelial biomarkers by cells cultured on micropatterned scaffolds. | Yan et al., |
| HUVECs | Poly (lactic-co-glycolic acid) | Aligned fibers; Diameter: 0.5–10 μm. | Cell alignment and polarization on fibers with intermediate diameter; Stimulation of a migratory phenotype. | Ahmed et al., |
| C2C12 myoblasts and neonatal rat cardiomyocytes | Poly (glycerol sebacate) and poly (caprolactone) | Random fibers; Diameter: 1.2 μm; Patterning of electrospun mats using a microstructured collector; Parallel grooves of 10 μm diameter and interspatial distances of 200 and 7 μm; Square-shaped structures of 100 μm size and 50 μm distance. Surface roughness: 0.4–1.3 μm. | Cells alignment along parallel grooves topography. | Tallawi et al., |
| C2C12 myoblasts | Poly (caprolactone) | Random and aligned fibers; Diameter: 0.8-2.5 μm. Distance between aligned fibers: 2.2 and 13.8 μm. | Uniaxial orientation and elongation of cells on aligned fibers; Myogenic differentiation and elongation of myotubes along the aligned fibers. | Park et al., |
| C2C12 myoblasts | Poly (L-lactic acid) | Random fibers; Diameter: 720 nm; Patterning of electrospun mats using a femtosecond laser ablation; Parallel grooves of 5 μm width and spacing of 10, 25, and 80 μm. | Cells alignment along the micro-grooves; Regulation of cellular adhesive morphology, proliferation, and distribution of focal adhesion proteins. | Jun et al., |
| C2C12 myoblasts | Poly (ε-caprolactone) and poly (lactic-co-glycolic acid) | Random and aligned fibers; Diameter: 0.4–3.2 μm; | Increased alignment and aspect ratio of myotubes on aligned fibers. | Abarzúa-Illanes et al., |
| Neuron-like PC12 cells | Poly (caprolactone) and gelatin; Collagen; Polystyrene | Random fibers; Diameter: 440 nm; Patterning of electrospun mats using polystyrene 5 μm wide grooves and 18 μm diameter wells by thermal fusion. | Increased extension of neurites within the grooves; High neurite length per differentiated cell for the micropatterned substrates. | Malkoc et al., |
| Neural stem cells | Polyphenylene sulfone | Random and aligned fibers; Diameter: 735 nm. | Enhanced neuronal differentiation on the fibrous scaffolds; Growth and activity of primary neural cells on nanofibres; Parallel axon growth on aligned nanofibers. | Hajiali et al., |
Summary of main results reported in selected recent papers on electrospun scaffolds used in vivo experiments.
| Mono-component (MC) and bi-component (BC) conduits made of random PCL and PCL/gelatin fibers, respectively, implanted in rat sciatic nerve defects. | Formation of numerous myelinated axons and vasculature in the MC conduit group; fibrous tissue and inflammatory cells with no evidence of myelinated axons for BC conduits, due to gelatin degradation or mechanical collapse. Superior functional recovery recorded for MC conduits over BC conduits after 18 weeks of implantation. Recover of tibialis anterior and gastrocnemius muscle weights after 18 weeks for MC conduit group; muscle atrophy for BC conduit group. | Cirillo et al., |
| Random and aligned PCL-PEG fibers within a chitosan matrix implanted in a surgically created defect in maxillary first molar of rats. | Rat bone marrow mesenchymal stem cells (rBMSCs) with spindle shape and oriented actin filaments on scaffolds consisting of aligned fibers; while rBMSCs with polygonal or dentritic shape of scaffolds with random fibers. Increased ligamentogenesis and partially decreased osteogenesis for rBMSCs for scaffolds with aligned fibers. Increased stability and maturation of the periodontal ligament matrix, and increased regenerated bone volume and density for scaffolds with aligned fibers. | Jiang et al., |
| Vascular grafts with oriented PCL microfibers coated with electrospun random PCL nanofibres and implanted in rat abdominal aorta. | Enhanced growth of vascular smooth muscle cells (VSMCs) after 2 and 4 weeks of implantation. Regeneration of arteries with notable VSMCSs vaso-activity after 12 weeks of implantation, and synthesis of elastin and collagen type I/II with phenotypic and structural similarities to the native arteries. Complete endothelialisation after 4 weeks with endothelial cells (ECs) having a morphology similar to the native endothelium. Regeneration of healthy and functional neaoarteries where VSMCs and ECs response to the endothelial-specific activator acetylcholine, hence showing vasodilation. | Zhu et al., |
| Random PCL fibers implanted into the subcutaneous tissues of rats. | Macrophage recruitment, elongation and increased the expression of Arginase-1 or IL-4. Macrophage phenotype transition from M1 (pro-inflammatory) to M2 (pro-healing). High adsorption of proteins, particularly the chemotactic factor Complement C3a, vitronectin and fibronectin. Macrophages' secretion of high levels of SDF-1, a chemokine that mediates MSCs recruitment by interacting with CXC chemokine receptors on the MSCs membrane. | Zhang et al., |
| Conditioned-medium (CM) from Ad-MSCs cultured on oriented (AEF and MEF) PCL fibers. CM applied to a skin wound-healing model. | High wound closure rate for animals treated with the MSC-MEF CM. Collagen deposition in a fine reticular pattern for group of MSC-MEF CM. High density of macrophages and M2 macrophages for MSC-MEF CM. | Su et al., |
| PCL-PTHF urethane (P fibers) and PCL-PTHF urethane/collagen I (PC fibers) implanted in defects on the surface of the patellar groove of rat femurs. | After 4 weeks of implantation, newly formed tissues for both P and PC groups with minor inflammatory cells after 4 weeks. Fibrous tissue with a loose and detached for P group; fibrocartilage-like tissue and integration with the surrounding tissue for PC group. After 8 weeks of implantation, hyaline cartilage with round cells in the lacuna for both P and PC groups. More uniform and compact tissue for PC group. Stronger positive immunohistochemical staining of collagen II for PC group after 4 weeks. | Jiang et al., |
| Random and aligned PCL/Collagen I fibers used to treat full-thickness wounds in diabetic rats. | Remarkable increase of the expression of Arginase I and NOS2 for oriented fibers and consequent stimulation of macrophages transition from M1 to M2. Detection of new blood vessels at the wound site for scaffolds with oriented fibers. Infiltration of fibroblasts and macrophages and collagen deposition in the wound sites for all nanofiber groups. | Sun et al., |
| Random and aligned PLLA fibers implanted in rats for Achilles tendon repair. | After implantation, for scaffolds with aligned fibers, tendon-like tissue formation, continuous collagen fibers, expression of tendon-specific markers, such as scleraxis, tenomodulin, and Msx-2 (role in preventing tendons from mineralizing). After implantation, for scaffolds with random fibers, substantial chondrogenesis and tissue ossification, high levels of chondro-lineage specific genes, such as collagen type II, Sox9, and aggrecan. | Yin et al., |
| Polyurethane (PU) grafts with low (void fraction of 53%) and high (void fraction of 80%) porosity, implanted into the infrarenal aorta of rats. | Growth of vimentin-positive fibroblasts, actin-positive myofibroblasts and desmin-positive myocytes at the adventitial interface of the grafts in the early phase after implantation. Growth of myofibroblasts and myocytes within the whole graft wall of the coarse-mesh grafts, 6 months after implantation; while limited cell growth for fine-mesh grafts. Superior cell migration and long-term survival of cells for grafts with high porosity than for grafts with low porosity. | Bergmeister et al., |
Figure 1Confocal images of HUVECs (actin filaments in red and nuclei in blue) cultured for 7 days on (O) standard petri dish (typical cobblestone-like structure) and electrospun scaffolds with different patterns: (A) nonwoven (cells with flat, round shape morphology); (B) single directionally aligned pattern (cell alignment along fibers direction, green arrows); (C1–E1) anisotropic aligned patterns with interval distances of 300, 800, and 1500 μm, respectively; (C1′-E1′) anisotropic aligned patterns with interval distances of 300, 800, and 1500 μm (high magnification images), respectively (spindle shape along the long fiber axes for cells between the embossments) (C2′- E2′) anisotropic aligned patterns with interval distances of 300, 800, and 1500 μm, respectively (polygonal shape with random stretching for cells on the embossments). (F) SEM image of anisotropic aligned pattern. Scale bar = 50 μm. Reprinted with permission from Xu et al. (2015). Copyright 2018 of the American Chemical Society.
Figure 2(A) Fluorescence images of a HeLa cell stained for actin on a crossbow microstructure coated with fibronectin. Given a micro-pattern, cell shape can be observed with optical microscopy (direct problem). Give a cell shape, it is not always straightforward to experimentally identify the original pattern (inverse problem). (B) CPM can be used to predict cell shape on a microstructure, and genetic algorithms can help to define pattern geometry. Reproduced with permission from Albert and Schwarz (2016c). Copyright 2016 of the Royal Society of Chemistry.
Clinical trials of electrospun scaffolds.
| Experimental study of the vascular prosthesis manufactured by electrospinning (NCT02255188) | Completed | Arterial occlusive disease | Determination of the safety of electrospun vascular grafts for the development of thrombosis. | 120 | PCL grafts; PCL/gelatin grafts; PLGA/PCL/gelatin grafts; Nylon 6 grafts. | Not currently available |
| EktoTherix™ regenerative tissue scaffold for repair of surgical excision wounds (NCT02409628) | Completed | Non-melanoma skin cancer; Basal cell carcinoma; Squamous cell carcinoma | Assessment of the safety and performance of EktoTherix™ Tissue Repair Scaffold for the treatment of full-thickness, dermatologic wounds due to the surgical removal of non-melanoma skin cancers. | 12 | EktoTherix™ Tissue Repair Scaffold: | Not currently available |
| Clinical trial for the treatment of diabetic foot ulcers using a nitric oxide releasing patch: PATHON | Completed | Diabetic foot | Evaluation of the effectiveness and safety of nitric oxide releasing wound dressings for the treatment of diabetic foot ulcers. | 100 | Multilayer polymeric transdermal patch with a continuous release of nitric oxide (polyurethane-based fibers). | Not currently available |
| Controlled nitric oxide releasing patch vs. meglumine antimoniate in the treatment of cutaneous Leishmaniasis | Terminated | Cutaneous Leishmaniasis | Evaluation of the effectiveness of a nitric oxide topical donor for the treatment of cutaneous leishmaniasis. | 178 | Multilayer polymeric transdermal patch with a continuous release of nitric oxide (polyurethane-based fibers). | Not currently available |
The data are obtained from ClinicalTrials.gov, a resource provided by the U.S. National Library of Medicine (Accessed on September 2018).